TerrAscend (TSNDF) Operating Leases (2021 - 2026)
TerrAscend's (TSNDF) quarterly Operating Leases came in at $29.5 million in Q1 2026, down 28.65% year-on-year from $41.4 million in Q1 2025, and up 3.47% on a QoQ basis from $28.6 million in Q4 2025.
TerrAscend (TSNDF) Operating Leases (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Operating Leases data on file, last reported at $29.5 million in Q1 2026.
- On a quarterly basis, Operating Leases fell 28.65% year-over-year to $29.5 million in Q1 2026; TTM through Mar 2026 was $29.5 million, a 28.65% decrease from a year earlier, with the FY2025 full-year figure at $28.6 million, down 6.88% from the prior year.
- Operating Leases for Q1 2026 stood at $29.5 million, up from $28.6 million in the prior quarter.
- Over the last five years, Operating Leases for TSNDF reached as high as $46.4 million in Q3 2023 and fell as low as $28.6 million in Q4 2025.
- Historically, Operating Leases has averaged $35.7 million across 5 years, with a median of $31.8 million in 2023.
- Across the five-year window, Operating Leases soared 49.52% in 2023 and sank 32.43% in 2024, its largest moves.
- Year by year, Operating Leases stood at $31.5 million in 2022, then soared by 43.87% to $45.4 million in 2023, then sank by 32.43% to $30.7 million in 2024, then retreated by 6.88% to $28.6 million in 2025, then gained by 3.47% to $29.5 million in 2026.
- Per Business Quant data, the three most recent Operating Leases figures were $29.5 million in Q1 2026, $28.6 million in Q4 2025, and $30.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.55 Mn |
| Dec 31, 2025 | 28.56 Mn |
| Sep 30, 2025 | 30.54 Mn |
| Jun 30, 2025 | 31.04 Mn |
| Mar 31, 2025 | 41.41 Mn |
| Dec 31, 2024 | 30.66 Mn |
| Sep 30, 2024 | 43.10 Mn |
| Jun 30, 2024 | 42.65 Mn |
| Mar 31, 2024 | 43.97 Mn |
| Dec 31, 2023 | 45.38 Mn |
| Sep 30, 2023 | 46.44 Mn |
| Jun 30, 2023 | 35.21 Mn |
| Mar 31, 2023 | 31.84 Mn |
| Dec 31, 2022 | 31.55 Mn |
| Sep 30, 2022 | 31.06 Mn |
| Jun 30, 2022 | 31.68 Mn |
| Mar 31, 2022 | 32.45 Mn |
| Dec 31, 2021 | 30.57 Mn |